| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.57B | 23.10B | 23.05B | 22.15B | 19.94B |
| Gross Profit | 11.54B | 11.20B | 10.76B | 9.33B | 8.54B |
| EBITDA | 4.40B | 4.49B | 4.15B | 3.54B | 3.16B |
| Net Income | 2.57B | 2.68B | 2.39B | 2.02B | 1.86B |
Balance Sheet | |||||
| Total Assets | 25.90B | 23.63B | 22.95B | 22.59B | 20.67B |
| Cash, Cash Equivalents and Short-Term Investments | 207.20M | 210.40M | 276.80M | 198.80M | 165.70M |
| Total Debt | 14.53B | 11.91B | 11.81B | 12.51B | 11.50B |
| Total Liabilities | 21.30B | 19.58B | 19.24B | 19.49B | 18.23B |
| Stockholders Equity | 4.60B | 4.05B | 3.72B | 3.10B | 2.44B |
Cash Flow | |||||
| Free Cash Flow | 2.65B | 2.08B | 2.63B | 1.28B | 1.87B |
| Operating Cash Flow | 3.45B | 3.15B | 3.52B | 1.92B | 2.24B |
| Investing Cash Flow | -2.01B | -1.20B | -1.04B | -1.61B | -476.40M |
| Financing Cash Flow | -1.38B | -2.02B | -2.42B | -282.40M | -1.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $86.95B | 42.37 | 22.40% | 1.01% | 1.38% | -2.54% | |
71 Outperform | $14.62B | 21.98 | 22.72% | 1.96% | 3.09% | 12.25% | |
68 Neutral | $27.55B | 17.82 | 21.34% | 2.71% | -12.98% | -11.34% | |
67 Neutral | $89.84B | 35.35 | 59.39% | 0.98% | 0.96% | 1.96% | |
65 Neutral | $7.13B | 19.20 | 17.75% | ― | -1.83% | 40.64% | |
65 Neutral | $20.46B | ― | -0.80% | 1.74% | 2.42% | -196.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
On February 9, 2026, Sherwin-Williams amended its Amended and Restated Credit Agreement with Citicorp USA, Inc. and a syndicate of lenders to extend the maturity of $75 million in available commitments and letter-of-credit capacity from June 20, 2026 to December 20, 2030. The extension secures longer-term access to liquidity and banking support, underscoring the company’s established relationships with commercial and investment banks that provide a range of financial services to Sherwin-Williams and its subsidiaries.
The most recent analyst rating on (SHW) stock is a Buy with a $385.00 price target. To see the full list of analyst forecasts on Sherwin-Williams Company stock, see the SHW Stock Forecast page.